Trial Profile
Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Jan 2016 New trial record
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium